Sun Biomedical (ASX:SBN) Marketable Securities : A$0.00 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Sun Biomedical Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Sun Biomedical's Marketable Securities for the quarter that ended in Dec. 2023 was A$0.00 Mil.

Sun Biomedical Marketable Securities Historical Data

The historical data trend for Sun Biomedical's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Biomedical Marketable Securities Chart

Sun Biomedical Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Marketable Securities

Get a 7-Day Free Trial

Sun Biomedical Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Marketable Securities	Get a 7-Day Free Trial															-	-	-	-	-

Sun Biomedical Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Sun Biomedical (ASX:SBN) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Sun Biomedical Marketable Securities Related Terms

Thank you for viewing the detailed overview of Sun Biomedical's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sun Biomedical (ASX:SBN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sun Biomedical Ltd (ASX:SBN) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

DXB:Australia

Address

425 Smith Street, Fitzroy, VIC, AUS, 3065

Website

https://www.dimerix.com

Dimerix Ltd is a biopharmaceutical company developing innovative new therapies in areas with unmet medical needs. The company is developing five product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for COVID-19 pneumonia patients in ICU; DMX-200 for respiratory complications in Covid-19 patients; and DMX-700 for COPD; as well as the proprietary ReceptorHIT assay technology.

Sun Biomedical (ASX:SBN) Headlines

No Headlines